Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2025-12-27 @ 11:37 PM
Study NCT ID:
NCT02890004
Status:
UNKNOWN
Last Update Posted:
2018-02-23
First Post:
2016-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Study of Patients With Subarachnoid Hemorrhage
Sponsor:
Hospices Civils de Lyon
Organization:
Study Overview
Official Title:
A Prospective, Observational Registry of Patient With Subarachnoid Hemorrhage in Neurocritical Care Unit
Status:
UNKNOWN
Status Verified Date:
2018-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ProReSHA
Brief Summary:
This prospective, observational study aim to identify :
* Prognostic factor of patients with subarachnoid haemorrhage in neuro intensive care unit
* The impact of standard therapeutic used (surgery, embolization ; medical treatment of vasospasm ; treatment of complications like hyponatremia, stress myocardiopathy, …)
* Prognostic factor of patients with subarachnoid haemorrhage in neuro intensive care unit
* The impact of standard therapeutic used (surgery, embolization ; medical treatment of vasospasm ; treatment of complications like hyponatremia, stress myocardiopathy, …)
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: